Splenic marginal zone lymphoma differential diagnosis: Difference between revisions

	Splenic marginal zone lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Splenic marginal zone lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Splenic marginal zone lymphoma differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Splenic marginal zone lymphoma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Splenic marginal zone lymphoma differential diagnosis
CDC on Splenic marginal zone lymphoma differential diagnosis
Splenic marginal zone lymphoma differential diagnosis in the news
Blogs on Splenic marginal zone lymphoma differential diagnosis
Directions to Hospitals Treating Splenic marginal zone lymphoma
Risk calculators and risk factors for Splenic marginal zone lymphoma differential diagnosis

Revision as of 19:24, 14 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Splenic marginal zone lymphoma must be differentiated from other diseases such as chronic lymphocytic leukemia, follicular lymphoma, and mantle cell lymphoma.


Differential Diagnosis	CD5	CD10	Cyclin-D1

Splenic marginal zone lymphoma	Negative	Negative	Negative
Chronic lymphocytic leukemia	Positive	Negative	Negative
Follicular lymphoma	Negative	Positive	Positive
Mantle cell lymphoma	Positive	Negative	Positive

Splenic marginal zone lymphoma must be differentiated from other diseases such as:

@@ Line 29: / Line 29: @@
 '''Positive'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Follicular lymphoma'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
 '''Positive'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Positive'''
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
@@ Line 45: / Line 47: @@
 '''Positive'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
 ''' Positive'''